Medicrea submits 3-D-printed titanium interbody devices for FDA clearance: 4 insights

Lyon, France-based Medicrea filed its 510(k) submission to the FDA for its 3-D-printed titanium spinal interbody devices.

Advertisement

Here are four insights:

 

1. Medicrea executives expect FDA clearance for the devices before year’s end.

 

2. The 3-D printed titanium devices are compatible with the company’s UNiD Lab surgical planning technology.

 

3. The UNiD Lab services help a surgeon create 3D-printed interbody anatomical specifications as well as offer a predictive analysis of global spinal parameters.

 

4. By the end of 2016, surgeons had used the UNiD Rod technology in more than 1,110 procedures. The FDA cleared the technology in late 2014.

 

More articles on devices:
Where NuVasive will focus in the future — Alignment, radiation reduction and more
Johnson & Johnson Medical Device Companies launches orthopedic episode of care platform: 5 things to know
Mainstay Medical CEO to present at Medtech Showcase: 3 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.